Skip to main content
. 2012 Nov 28;7(11):e50163. doi: 10.1371/journal.pone.0050163

Figure 3. Distribution of explanatory variables between patients in high-use and low-use cetuximab hospitals (a) and infection rates (b).

Figure 3